Vaccine halves gonorrhoea rate in French study

Back to the "HIV and Co-Infections News" list

Study also demonstrates effectiveness of doxyPEP

A vaccine against gonorrhoea halved the rate of repeated infections in gay and bisexual men, according to a study presented by the French research agency ANRS at the 30th Conference on Retroviruses and Opportunistic Infections (CROI 2023) in Seattle.

The DOXYVAC study also looked at the effectiveness of taking the antibiotic doxycycline as post-exposure prophylaxis (‘doxyPEP’) against bacterial STIs in general.

Read the full story at Aidsmap.

 

Source : Aidsmap

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.